stage iv fallopian tube cancer ajcc v6 and v7
Showing 1 - 14 of 14
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma
Active, not recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +29 more
- Bevacizumab
- +4 more
-
Birmingham, Alabama
- +572 more
Jan 28, 2023
Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7
Active, not recruiting
- Stage III Fallopian Tube Cancer AJCC v7
- +14 more
- Epacadostat
- +2 more
-
Minneapolis, Minnesota
- +1 more
Jan 27, 2023
Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United
Active, not recruiting
- Metastatic Fallopian Tube Carcinoma
- +11 more
- Berzosertib
- +4 more
-
Phoenix, Arizona
- +13 more
Dec 2, 2022
Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7
Active, not recruiting
- Stage III Fallopian Tube Cancer AJCC v7
- +14 more
- Carboplatin
- +4 more
-
Houston, Texas
- +4 more
Oct 20, 2022
Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7
Active, not recruiting
- Stage III Fallopian Tube Cancer AJCC v7
- +14 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jun 24, 2022
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +25 more
- Carboplatin
- +3 more
-
Goodyear, Arizona
- +111 more
Jun 1, 2022
Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Ovarian Mass Trial in United States (Laboratory
Completed
- Fallopian Tube Serous Adenocarcinoma
- +18 more
- Laboratory Biomarker Analysis
- BMN 673
-
Houston, Texas
- +5 more
Feb 11, 2022
Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States
Completed
- Fallopian Tube Carcinoma
- +37 more
- Bevacizumab
- +5 more
-
Birmingham, Alabama
- +22 more
Oct 19, 2021
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +26 more
- Clinical Observation
- +4 more
-
Birmingham, Alabama
- +314 more
Sep 28, 2021
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
Completed
- Fallopian Tube Clear Cell Adenocarcinoma
- +37 more
- Bevacizumab
- +5 more
-
Birmingham, Alabama
- +502 more
Apr 13, 2021
Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New
Withdrawn
- Endometrial Carcinoma
- +55 more
- Internet-Based Intervention
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 16, 2021
Stage IV Fallopian Tube Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v6 and v7, Stage IV Primary Peritoneal Cancer AJCC
Completed
- Stage IV Fallopian Tube Cancer AJCC v6 and v7
- +2 more
- Floxuridine
- +3 more
-
Scottsdale, Arizona
- +4 more
Jul 1, 2020
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
Completed
- Fallopian Tube Clear Cell Adenocarcinoma
- +34 more
- Chemotherapy
- +3 more
-
Gilbert, Arizona
- +6 more
Aug 27, 2019
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
Unknown status
- Fallopian Tube Clear Cell Adenocarcinoma
- +32 more
- Behavioral Dietary Intervention
- +7 more
-
Birmingham, Alabama
- +686 more
Feb 14, 2018